GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

PACB · Mar 31, 2025

PACIFIC BIOSCIENCES OF CALIFORNIA, INC.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]

Inspectable configuration

State dimensions

Filing0001299130-25-000102General Corporate

Capex intensityRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.capex_revenue_ratio

3.74% · OPTIONAL · NOT_ENOUGH_HISTORY

Operating cash generationRAWCurrent state valid · history insufficient

Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

-118.58% · OPTIONAL · NOT_ENOUGH_HISTORY

Revenue growthRAWCurrent state valid · history insufficient

Evidence method

Yoy · gp.fundamentals.revenue

-4.27% · CORE · NOT_ENOUGH_HISTORY

Inventory pressureRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.inventory_revenue_ratio

145.36% · OPTIONAL · NOT_ENOUGH_HISTORY

Gross marginRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.gross_margin

-3.69% · CORE · NOT_ENOUGH_HISTORY

Operating marginRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.operating_margin

-1154.51% · CORE · NOT_ENOUGH_HISTORY

R&D intensityRAWCurrent state valid · history insufficient

Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

78.20% · OPTIONAL · NOT_ENOUGH_HISTORY

SBC intensityRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

24.77% · OPTIONAL · NOT_ENOUGH_HISTORY

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History8 statesHistory building

Mar 31, 20240/7 normalizedLevel 3 Jun 30, 20240/7 normalizedLevel 3 Sep 30, 20240/7 normalizedLevel 3 Mar 31, 20250/8 normalizedLevel 3 Jun 30, 20250/8 normalizedLevel 3 Sep 30, 20250/8 normalizedLevel 3 Mar 31, 20260/8 normalizedLevel 3 Jun 30, 20260/8 normalizedLevel 3

Period transition

What moved in the state?

Capex Intensity Increased

Previous: -1.97%
Current: 3.74%
Delta: 5.71%

Cash Generation Decreased

Previous: -113.75%
Current: -118.58%
Delta: -4.83%

Inventory Pressure Decreased

Previous: 164.48%
Current: 145.36%
Delta: -19.11%

Margin Decreased

Previous: 25.03%
Current: -3.69%
Delta: -28.72%

Profitability Decreased

Previous: -160.32%
Current: -1154.51%
Delta: -994.18%

R And D Intensity Increased

Previous: 63.84%
Current: 78.20%
Delta: 14.36%

Sbc Intensity Decreased

Previous: 45.69%
Current: 24.77%
Delta: -20.92%

Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.

Research Graph

Related governed research

Transitioned To · PACB Fundamental State →Has State · PACIFIC BIOSCIENCES OF CALIFORNIA, INC. →Transitioned To · PACB Fundamental State →Transitioned To · PACB CAPEX_INTENSITY_INCREASED →Transitioned To · PACB CASH_GENERATION_DECREASED →Transitioned To · PACB INVENTORY_PRESSURE_DECREASED →Transitioned To · PACB MARGIN_DECREASED →Transitioned To · PACB PROFITABILITY_DECREASED →Transitioned To · PACB R_AND_D_INTENSITY_INCREASED →Transitioned To · PACB SBC_INTENSITY_DECREASED →

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.